Covid Shots Worked Better for Obese Than Underweight in UK Study
(Bloomberg) -- People who are underweight or obese are most at risk of severe Covid, but a UK study found that two doses of vaccine still protect both groups well.
The researchers, who focused on patients at the two extremes of the body mass index scale, found that the shots worked slightly better for those at the high end of the measure in a study published in medical journal The Lancet Diabetes & Endocrinology on Friday.
The scientists used health records of more than 9 million patients from generalist practices in England taking part in the database QResearch.
“Our findings provide further evidence that Covid-19 vaccines save lives for people of all sizes,” said Carmen Piernas, the study's lead author and a lecturer at the University of Oxford's Nuffield Department of Primary Care Health Sciences.
Even so, the researchers found that people with extreme BMIs were at higher risk of severe disease than others with a healthy BMI.
The data also highlight the need to increase vaccine uptake in people who are underweight, a category that's less immunized, according to Piernas.
More stories like this are available on bloomberg.com
©2022 Bloomberg L.P.
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.